1218996-2018-00040 addendum.Customer called indicating their leadcare ii capillary results inconsistent with venous reference results.These results were collected over a year time period, and traceability to the lots used during testing are not available for investigative evaluation.The unit was returned for testing after the original mdr [1218996-2018-00040] was submitted on 17nov2018.Testing performed: test 2 sets of whole blood patient samples in duplicates on both returned analyzer wlc09319 and in house analyzer wlc00105 against gfaas results.Conclusion: all qc and whole blood samples tested on both the in-house analyzer and returned analyzer generated results that correlated well with gfaas no reported harm or injuries occurred as a result of this issue.Customer coplaint: (b)(6).After further investigation it has been confirmed that none of the blood lead sample results are considered reportable events.Data below: sample 1: leadcare ii 7.1ug/dl vs labcorp: 10 ug/dl, not reportable, sample 2: leadcare ii 5.1 ug/dl vs labcorp: 11 ug/dl, not reportable, sample 3: leadcare ii: 8.5 ug/dlvs labcorp: 11 ug/dl, not reportable, sample 4: leadcare ii: 9.5 ug/dl vs labcorp: 13 ug/dl.Not reportable.
|